.

Megadeth's Dave Mustaine Says 'I'm Back' Following Cancer Fight


William Lee | 01-18-2020

Share on Facebook Share on Twitter Pin it Share on Reddit email this article

Megadeth

Megadeth cofounder Dave Mustaine took to social media on Friday (January 17th) and declared "I'm back" following his treatment for throat cancer.

Mustaine revealed that he had been diagnosed with cancer back in June of last year, which forced the band to cancel their planned shows so that he could undergo treatment.

He said at the time that his doctors felt that the treatment had a "a 90% success rate" and it appears that they were right with Dave sharing a photo and the "I'm back" declaration. See the post here

Megadeth will be returning to the road later this month for a European tour with Five Finger Death Punch, which will be the band's first shows since Dave revealed that he was battling cancer.
A week away from commencing a tour of Europe with Five Finger Death Punch, Mustaine made the proclamation this evening via Twitter (see below). These will be Megadeth's first shows since Mustaine's cancer diagnosis.


Related Stories


Megadeth Address David Ellefson Controversy

Megadeth's David Ellefson Denies Grooming Allegation

Megadeth's David Ellefson Launches Video Podcast

Megadeth, Lamb Of God, Trivium and In Flames Tour Dates Revealed

Megadeth's David Ellefson Announces Bass Chronicles Concert Series

Megadeth Wrapping Up Work On New Album Says Mustaine

Megadeth's Ellefson Teams Up With Jeff Scott Soto

Megadeth's David Ellefson Set Release Date For 'Dwellers'

Eddie Van Halen's Influence Went Beyond Guitar Says Megadeth Star

New Megadeth Album Is Almost Done Says Ellefson

More Megadeth News



advertisement

advertisement


Follow Us: Facebook Twitter Feeds

Contact Us - Privacy - antiMusic Email - Why we are antiMusic

Copyright© 1998 - 2021 Iconoclast Entertainment Group All rights reserved.

Please click here for legal restrictions and terms of use applicable to this site. Use of this site signifies your agreement to the terms of use.